Breaking Finance News

Touchstone Innovations PLC (LON:IVO) has been downgraded to Hold in a statement by N+1 Singer earlier today.

Having a price of 291.88GBX, Touchstone Innovations PLC (LON:IVO) traded -1.70% lower on the day. With the last close down -12.45% from the two hundred day average, compared with the S&P 500 Index which has increased 0.04% over the same period. Touchstone Innovations PLC has recorded a 50-day average of 278.32GBX and a two hundred day average of 296.99GBX. Volume of trade was down over the average, with 3,566 shares of IVO changing hands under the typical 50,059

N+1 Singer has downgraded Touchstone Innovations PLC (LON:IVO) to Hold in a statement released on Wednesday June 21, 2017.

Performance Chart

Touchstone Innovations PLC (LON:IVO)

With a total market value of 0 GBX, Touchstone Innovations PLC has with a one year low of 231.19GBX and a one year high of 484.75GBX .

A total of 2 analysts have released a research note on Touchstone Innovations PLC. One analyst rating the company a strong buy, one analyst rating the company a buy, one analyst rating the company a hold, zero analysts rating the company a underperform, and finally zero analysts rating the company a sell with a 12-month price target of 470.50GBX.

More About Touchstone Innovations PLC (LON:IVO)

Touchstone Innovations plc, formerly Imperial Innovations Group plc, is a technology commercialization company. The Company creates, builds and invests in technology companies and licensing opportunities developed from scientific research focusing on the Golden Triangle. The Company has operations in London, Cambridge and Oxford. The Company supports scientists and entrepreneurs in the commercialization of their ideas and intellectual property by the formation of new companies, providing facilities in the early stages, providing investment and co-investment to manage development, providing operational knowhow and recruiting management teams. It also runs a technology incubator in London. The Company invests in a range of sectors, which include therapeutics, medtech and medical devices, engineering and materials, and information and communications technology. It has access to intellectual property developed at Imperial College London and networks around London, Cambridge and Oxford.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.